help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, H. P.
Right arrow Articles by Gabbiani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, H. P.
Right arrow Articles by Gabbiani, G.

American Journal of Pathology, Vol 145, 105-113, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Morphological and immunochemical differences between keloid and hypertrophic scar

HP Ehrlich, A Desmouliere, RF Diegelmann, IK Cohen, CC Compton, WL Garner, Y Kapanci and G Gabbiani
Department of Surgery, Milton S. Hershey Medical Center, Hershey, Pennsylvania.

There are two types of excessive scarring, keloid and hypertrophic scar. Contrary to hypertrophic scars, keloids do not regress with time, are difficult to revise surgically, and do not provoke scar contractures. These two lesions require different therapeutic approaches but are often confused because of an apparent lack of morphological differences. We have investigated the collagen organization and the possible presence of alpha-smooth muscle (SM) actin-expressing myofibroblasts in these conditions. Keloids contain large, thick collagen fibers composed of numerous fibrils closely packed together. In contrast hypertrophic scars exhibit modular structures in which fibroblastic cells, small vessels, and fine, randomly organized collagen fibers are present. We confirm that such nodular structures are always present in hypertrophic scar and rarely in keloid. Furthermore, only nodules of hypertrophic scars contain alpha-SM actin-expressing myofibroblasts. Electron microscopic examination supports the above-mentioned differences in collagen organization and in fibroblastic features and shows the presence of an amorphous extracellular material surrounding fibroblastic cells in keloid. The presence in hypertrophic scar myofibroblasts of alpha-SM actin, the actin isoform typical of vascular SM cells, may represent an important element in the pathogenesis of contraction. Interestingly, when placed in culture fibroblasts from hypertrophic scars and keloid express similar amounts of alpha-SM actin, suggesting that local microenvironmental factors influence in vivo the expression of this protein. Thus several morphological and immunohistochemical differences exist between hypertrophic scar and keloid that are useful for the biological and pathological characterization of the two lesions.


This article has been cited by other articles:


Home page
Biophys. JHome page
C. B. Raub, J. Unruh, V. Suresh, T. Krasieva, T. Lindmo, E. Gratton, B. J. Tromberg, and S. C. George
Image Correlation Spectroscopy of Multiphoton Images Correlates with Collagen Mechanical Properties
Biophys. J., March 15, 2008; 94(6): 2361 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Arch Facial Plast SurgHome page
V. Da Costa, R. Wei, R. Lim, C.-H. Sun, J. J. Brown, and B. J.-F. Wong
Nondestructive Imaging of Live Human Keloid and Facial Tissue Using Multiphoton Microscopy
Arch Facial Plast Surg, January 1, 2008; 10(1): 38 - 43.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Aarabi, K. A. Bhatt, Y. Shi, J. Paterno, E. I. Chang, S. A. Loh, J. W. Holmes, M. T. Longaker, H. Yee, and G. C. Gurtner
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis
FASEB J, October 1, 2007; 21(12): 3250 - 3261.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J. G Parikh, R. N Khurana, M. M Lai, A. Rodriguez, and N. A Rao
Keloid of the conjunctiva simulating a conjunctival malignancy
Br. J. Ophthalmol., September 1, 2007; 91(9): 1251 - 1251.
[Full Text] [PDF]


Home page
Biophys. JHome page
C. B. Raub, V. Suresh, T. Krasieva, J. Lyubovitsky, J. D. Mih, A. J. Putnam, B. J. Tromberg, and S. C. George
Noninvasive Assessment of Collagen Gel Microstructure and Mechanics Using Multiphoton Microscopy
Biophys. J., March 15, 2007; 92(6): 2212 - 2222.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman
Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair
J. Dent. Res., October 1, 2005; 84(10): 871 - 880.
[Abstract] [Full Text] [PDF]


Home page
Arch Facial Plast SurgHome page
M. M. Hanasono, J. Lum, L. A. Carroll, A. A. Mikulec, and R. J. Koch
The Effect of Silicone Gel on Basic Fibroblast Growth Factor Levels in Fibroblast Cell Culture
Arch Facial Plast Surg, March 1, 2004; 6(2): 88 - 93.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara
Adverse Effects of Dietary Glycotoxins on Wound Healing in Genetically Diabetic Mice
Diabetes, November 1, 2003; 52(11): 2805 - 2813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. J. Lim, T.-T. Phan, E.-K. Tan, T.-T. T. Nguyen, E. Tran, M. T. Longaker, C. Song, S.-T. Lee, and H.-T. Huynh
Synchronous Activation of ERK and Phosphatidylinositol 3-Kinase Pathways Is Required for Collagen and Extracellular Matrix Production in Keloids
J. Biol. Chem., October 17, 2003; 278(42): 40851 - 40858.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Wendling, A. Marchand, A. Mauviel, and F. Verrecchia
5-Fluorouracil Blocks Transforming Growth Factor-{beta}-Induced {alpha}2 Type I Collagen Gene (COL1A2) Expression in Human Fibroblasts via c-Jun NH2-Terminal Kinase/Activator Protein-1 Activation
Mol. Pharmacol., September 1, 2003; 64(3): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
T. P. Amadeu, B. Coulomb, A. Desmouliere, and A. M. A. Costa
Cutaneous Wound Healing: Myofibroblastic Differentiation and in Vitro Models
International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 60 - 68.
[Abstract] [PDF]


Home page
BMJHome page
A Bayat, D A McGrouther, and M W J Ferguson
Skin scarring
BMJ, January 11, 2003; 326(7380): 88 - 92.
[Full Text] [PDF]


Home page
JBJSHome page
M. Paavola, P. Kannus, T. A.H. Jarvinen, K. Khan, L. Józsa, and M. Jarvinen
Achilles Tendinopathy
J. Bone Joint Surg. Am., December 4, 2002; 84(11): 2062 - 2076.
[Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Yamate, M. Maeda, S. J. Benn, J. E. Laithwaite, A. Allan, M. Ide, M. Kuwamura, T. Kotani, S. Sakuma, and J. Lamarre
Differential Effects of Transforming Growth Factor-{beta}1, a Fibrogenic Factor, on Macrophage-Like Cells (HS-P) and Myofibroblastic Cells (MT-9) In Vitro
Toxicol Pathol, June 1, 2001; 29(4): 483 - 491.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
A. M. A. Costa, S. Peyrol, L. C. Porto, J.-P. Comparin, J.-L. Foyatier, and A. Desmouliere
Mechanical Forces Induce Scar Remodeling : Study in Non-Pressure-Treated versusPressure-Treated Hypertrophic Scars
Am. J. Pathol., November 1, 1999; 155(5): 1671 - 1679.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
H. P. Ehrlich, K. A. Keefer, R. L. Myers, and A. Passaniti
Vanadate and the Absence of Myofibroblasts in Wound Contraction
Arch Surg, May 1, 1999; 134(5): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T W Beer, H Baldwin, L West, P J Gallagher, and D H Wright
Mast cells in pathological and surgical scars
Br. J. Ophthalmol., June 1, 1998; 82(6): 691 - 694.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.